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Abstract: We present a case of basal cell adenocarcinoma (BCAC) in the tongue in a 65-year old male. This is an extremely rare 
presentation. BCAC generally occurs in the parotid gland and rarely involves the minor salivary glands. Few cases have been reported 
in literature with a variable presentation. The biopsy was formalin-fixed and paraffin-embedded. The sections were stained with routine 
Hematoxylin and Eosin. Immunohistochemistry was performed. Hematoxylin and eosin staining showed tumour composed of variable 
sized and shaped, nests and sheets of basaloid epithelial cells having hyperchromatic to vesicular nuclei. Immunohistochemistry was 
positive for Pancytokeratin, Epithelial membrane antigen and p53. The clinicopathological features and the cellular immunophenotype 
addressed the diagnosis towards BCAC of the tongue. The goal of this report is to increase awareness of this rare disease and to review 
and discuss the differential diagnosis and important considerations in treatment.
Keywords: basal cell adenocarcinoma, minor salivary gland, tongueGupta et al
128  Clinical Medicine Insights: Oncology 2010:4
Introduction
Basal cell adenocarcinomas (BCAC) are slow-growing 
tumours that most commonly involve the parotid gland 
and very rarely involve the minor salivary glands of 
the oral cavity.1 The average age of patients is 60 years, 
with no sex predilection.2 We present a case of basal 
cell adenocarcinoma in the tongue in a 65 year old 
male. Such a presentation is extremely rare. BCAC 
is believed to arise from pluripotent ductal reserve 
cells. Histopathology of BCAC is characterized by 
two cell types: small basaloid epithelial cells at the 
periphery  of  tumour  clusters,  and  larger  epithelial 
cells situated centrally in tumour clusters. Different 
histological  growth  patterns  are  seen,  ie,  solid, 
trabecular, tubular and membranous types. Criteria 
for  the  diagnosis  of  BCAC  include  infiltrative 
growth with possible perineural or vascular invasion. 
Differential diagnosis with high grade malignancies 
like adenoid cystic carcinoma is important because of 
the low malignant behaviour and good prognosis of 
BCAC. Immunohistochemistry reveals reactivity for 
cytokeratins, p53 and focally reactive for epithelial 
membrane antigen and S100 protein. It metastasizes 
seldom, but may recur locally. Although BCAC is 
a malignant counterpart of Basal Cell Adenoma, it 
often grows denovo.
case presentation
A 65-year old male reported with swelling in the throat 
for  two  months.  Swelling  was  also  accompanied 
with pain in the involved region. On examination, 
an  ulceroproliferative  growth  was  noticed  in  the 
posterior one-third of the tongue extending into the 
vallecula and crossing the midline. No lymph nodes 
in the neck were identified. Radiography revealed no 
abnormality. Imaging studies revealed no evidence 
of  tumour  elsewhere  in  the  body.  Wide  surgical 
excision with complete removal of the tumour was 
performed.
The surgical specimens were formalin-fixed and 
paraffin embedded. The sections were stained with 
routine Hematoxylin and Eosin stain. Special stains 
were performed including PAS-diastase and Mucicar-
mine.  Immunohistochemistry  was  performed  using 
avidin  biotin  complex  technique  and  diaminoben-
zidine as chromogen. The antibodies used included 
Pan-cytokeratin,  Epithelial  Membrane  Antigen, 
p53, Smooth Muscle Actin, and S-100, at suggested 
dilution.  We  also  performed  appropriate  routinely 
positive and negative controls.
Results
Macroscopically,  the  biopsy  specimen  consisted  of 
a single irregular soft tissue bit measuring 1 × 0.8 × 
0.4 cm, gray-tan in colour and firm in consistency. 
Microscopically,  the  section  showed  ulceration 
through the mucosa. Variable sized and shaped, nests 
and sheets of basaloid epithelial cells having hyper-
chromatic to vesicular nuclei (Fig. 1) were seen. Two 
types  of  basaloid  cells  were  observed:  dark  baso-
philic cells towards the periphery and pale basophilic 
cells towards the centre of the proliferation. Nuclear 
palisading was observed along the interface with the 
collagenous stroma. Intervening thick bands of col-
lageous  septa  were  observed.  Tumour  showed  an 
infiltrative growth pattern and focal areas of squamous 
cell differentiation. Mitotic activity was seen. No sali-
vary gland tissue was identified in the sections   studied. 
PAS-  diastase and mucicarmine were negative.
Immunohistochemical  evaluation  revealed  Pan-
cytokeratin (Fig. 2), Epithelial Membrane Antigen, 
p53 (Fig. 3) and S100 positivity. In contrast, Smooth 
Muscle Actin (SMA) was negative.
The  clinical  presentation  and  the  macroscopic 
aspect,  together  with  the  histological  pattern,  the 
cytological characteristics and the cellular immuno-
phenotype addressed the diagnosis towards Basal Cell 
Adenocarcinoma (solid pattern mixed with   trabecular 
pattern), in the tongue.
Discussion
Basal  cell  adenocarcinoma  (BCAC)  was  first 
recognised in 1978.3 Ellis and Gnepp first defined the 
histological features of BCAC in 1988. The clinic-
pathologic  features  of  this  tumour  were  defined 
in  1990  by  Ellis  and  Wiscivitch  in  their  study  of 
29 cases.4 In 1991, BCAC was included in the World 
Health Organization classification of salivary gland 
neoplasms.5  The  2005  World  Health  Organization 
classification  categorizes  BCAC  as  a  low-grade 
tumour with a favourable prognosis.1
BCAC’s  comprise  1.6%  of  all  salivary  gland 
neoplasm  and  2.9%  of  malignant  salivary  gland 
neoplasms.5 This tumour most commonly involves 
the parotid gland (90%) and very rarely the minor 
salivary glands of the oral cavity.1 Jones et al (2008)6 Basal cell adenocarcinoma- tongue
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Figure 2. Immunohistochemical staining showing diffuse positivity for 
cytoplasmic antigen pancytokeratin (×200).
Figure 1. Histologic appearance of solid/trabecular nests of cells with 
scant cytoplasm, vesicular nuclei and peripheral palisading. Overlying 
squamous epithelium is seen. Arrow indicates vascular invasion. Hema-
toxylin and eosin stain, magnification ×100.
states  that  minor  salivary  gland  tumours  typically 
occur on hard palate. Peel et al (2007)7 reported a 
case of minor salivary gland BCAC in buccal mucosa. 
Parashar et al (2007)8 has also described this tumour 
in the lip and tongue.
The average age of patients for BCAC is 60 years. 
No predilection for the occurrence of BCAC in either 
men or women is apparent. In our case, BCAC has been 
reported in a 65 year old male. Swelling is the predomi-
nant symptom in BCAC, which may occasionally show 
a rapid onset. Pain and tenderness may be present as an 
associated complaint.1 In our case, the patient reported a 
rapidly growing swelling associated with pain. Patients 
with BCAC may also develop multiple skin adnexal 
tumours and parotid basal cell adenocarcinomas.1
BCAC  most  frequently  occurs  in  the  superfi-
cial  lobe  of  the  parotid  gland.  The  cut-surface  is 
homogenous, grey, tan-white or brownish with cystic 
changes.  The  tumour  cells  are  basaloid  epithelial 
cells  which  vary  from  small,  dark  cells  to  larger, 
paler stained cells. BCAC has four major histological 
patterns: solid, membranous, trabecular and tubular.1 
The solid pattern, as seen in our case, is the most 
common and is characterized by variable sized and 
shaped, islands and nests of tumour cells separated 
by thin septa or thick bands of collagenous stroma. 
The membranous type is distinguished by excessive 
amounts of eosinophilic, Periodic Acid Schiff positive 
hyalinised basal lamina material that forms intercel-
lular droplets and peripheral membranes. Trabecular 
pattern is identified by the presence of interconnecting 
bands of basaloid cells. In the tubular type, there are 
luminal spaces among the basaloid cells. There are 
foci of squamous differentiation in some tumors.1
Most cases of BCAC are believed to develop de 
novo but as many as 25% of cases may arise from a 
pre-existing basal cell adenoma.9,10 The major patho-
logic differential diagnostic considerations for BCAC 
are basal cell adenoma, adenoid cystic carcinoma and 
Basaloid  squamous  cell  carcinoma  (BSCC).11  The 
distinguishing features of basal cell neoplasms have 
been illustrated in Table 1. Infiltration of tumour cells 
into parotid parenchyma, dermis, skeletal muscle, or 
periglandular fat distinguishes BCAC from basal cell 
adenoma. Vessel or peripheral nerve invasion is evident 
in about a fourth of the tumors.1 Distinguishing BCAC 
Figure 3. Increased proliferation detected by p53 immunostain. Magni-
fication (×100).Gupta et al
130  Clinical Medicine Insights: Oncology 2010:4
from adenoid cystic carcinoma (ACC) is important 
due to poor prognosis and higher prevalence of the 
latter disease. Major distinguishing features of ACC 
are  the  presence  of  dark  hyperchromatic  angulated 
nuclei which are in contrast to the vesicular nuclei in 
BCAC. The cribriform pattern which is commonly 
seen in ACC, is distinctive and not found in BCAC.12 
Due  to  the  above  differences, ACC  was  ruled  out 
during diagnosis. Another basaloid tumour showing 
similarity with BCAC is BSCC, a distinct variant of 
squamous  cell  carcinoma. The  basaloid  component 
of BSCC arranged in solid or trabecular pattern may 
resemble that of BCAC. The presence of squamous 
differentiation  and  invasive  squamous  cell  carci-
noma, form an integral component in BSCC but are 
not features of BCAC.12 The diagnosis of BSCC was 
also negated in the present case due to the absence of 
invasive squamous cell carcinoma component.
Immunohistochemical staining is variable. Tumour 
cells are reactive for cytokeratins and focally reac-
tive for S100 protein, epithelial membrane antigen 
(EMA), and carcinoembryonic antigen (CEA).1 The 
present case showed positivity for Pan-cytokeratin, 
EMA, S100 and p53. SMA was negative.
BCAC’s have a favourable prognosis as they sel-
dom metastasize and death of patients is rare.1 They 
are  locally  destructive  with  a  propensity  to  recur. 
Surgical  excision  with  a  wide  margin  to  ensure 
complete removal has been suggested as the primary 
treatment for BCAC.8 Enucleation or curettage is to be 
avoided. Radiotherapy has been proposed for lesions 
in the minor salivary glands because of the higher 
likelihood of vascular and neural invasion.13 Radio-
therapy has also been used for tumours with a diffuse 
infiltrating pattern to adjacent tissue. Scholtz A et al14 
suggest that the recurrence rate is about 25% to 30% 
and approximately 10% metastasize to regional lymph 
nodes or distant organs. It is necessary to differentiate 
BCAC from other basaloid cell tumours because of 
the differences in prognosis and potential differences 
in treatment.
Very little is known about the genetic makeup of 
BCAC. The role of specific chromosomal aberrations 
remains unclear, and additional studies are needed to 
determine important chromosomal deviations in the 
pathogenesis of these tumours.14
conclusions
BCAC of the tongue is an extremely rare presentation. 
Few cases of BCAC have been reported in literature 
involving the minor salivary glands and the tongue. 
Basal cell adenocarcinoma should be one of the diag-
nostic considerations in a patient with a rapidly grow-
ing swelling in the tongue associated with pain and 
tenderness.
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